ADAR1 Capital Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,341
| Closed | -$12.7K | – | 207 |
|
|
2025
Q1 | $12.7K | Sell |
1,341
-18,168
| -93% | -$172K | ﹤0.01% | 189 |
|
|
2024
Q4 | $175K | Sell |
19,509
-14,563
| -43% | -$131K | 0.04% | 152 |
|
|
2024
Q3 | $2.19M | Buy |
34,072
+11,336
| +50% | +$728K | 0.36% | 44 |
|
|
2024
Q2 | $1.71M | Buy |
22,736
+1,318
| +6% | +$98.9K | 0.32% | 42 |
|
|
2024
Q1 | $2.56M | Sell |
21,418
-24,518
| -53% | -$2.93M | 0.58% | 32 |
|
|
2023
Q4 | $3.82M | Buy |
+45,936
| New | +$3.82M | 1.36% | 16 |
|